{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:57:12Z","timestamp":1787237832526,"version":"build-2736575974"},"reference-count":51,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012128","name":"Austin Medical Research Foundation","doi-asserted-by":"publisher","award":["Walsh -2018, Perini -2018, Fifis -2019"],"award-info":[{"award-number":["Walsh -2018, Perini -2018, Fifis -2019"]}],"id":[{"id":"10.13039\/100012128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2020,3,25]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>It is now recognized that many anticancer treatments positively modulate the antitumor immune response. Clinical and experimental studies have shown that inhibitors of the classical renin\u2013angiotensin system (RAS) reduce tumor progression and are associated with better outcomes in patients with colorectal cancer. RAS components are expressed by most immune cells and adult hematopoietic cells, thus are potential targets for modulating tumor-infiltrating immune cells and can provide a mechanism of tumor control by the renin\u2013angiotensin system inhibitors (RASi).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To investigate the effects of the RASi captopril on tumor T lymphocyte distribution in a mouse model of colorectal liver metastases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Liver metastases were established in a mouse model using an autologous colorectal cancer cell line. RASi (captopril 750\u2009mg\/kg) or carrier (saline) was administered to the mice daily via intraperitoneal injection, from day 1 post-tumor induction to endpoint (day 15 or 21 post-tumor induction). At the endpoint, tumor growth was determined, and lymphocyte infiltration and composition in the tumor and liver tissues were analyzed by flow cytometry and immunohistochemistry (IHC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Captopril significantly decreased tumor viability and impaired metastatic growth. Analysis of infiltrating T cells into liver parenchyma and tumor tissues by IHC and flow cytometry showed that captopril significantly increased the infiltration of CD3\n                      <jats:sup>+<\/jats:sup>\n                      T cells into both tissues at day 15 following tumor induction. Phenotypical analysis of CD45\n                      <jats:sup>+<\/jats:sup>\n                      CD3\n                      <jats:sup>+<\/jats:sup>\n                      T cells indicated that the major contributing phenotype to this influx is a CD4 and CD8 double-negative T cell (DNT) subtype, while CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells decreased and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells remained unchanged. Captopril treatment also increased the expression of checkpoint receptor PD-1 on CD8\n                      <jats:sup>+<\/jats:sup>\n                      and DNT subsets .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Captopril treatment modulates the immune response by increasing the infiltration and altering the phenotypical composition of T lymphocytes and may be a contributing mechanism for tumor control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2019-000487","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T05:53:43Z","timestamp":1593150823000},"page":"e000487","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Immunomodulatory effects of renin\u2013angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9863-608X","authenticated-orcid":false,"given":"Dora Lucia","family":"Vallejo Ardila","sequence":"first","affiliation":[{"name":"Surgery, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0927-2008","authenticated-orcid":false,"given":"Katrina A","family":"Walsh","sequence":"additional","affiliation":[{"name":"Surgery, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-0560","authenticated-orcid":false,"given":"Theodora","family":"Fifis","sequence":"additional","affiliation":[{"name":"Surgery, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2170-4723","authenticated-orcid":false,"given":"Rita","family":"Paolini","sequence":"additional","affiliation":[{"name":"Surgery, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2219-0007","authenticated-orcid":false,"given":"Georgios","family":"Kastrappis","sequence":"additional","affiliation":[{"name":"Surgery, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1349-0884","authenticated-orcid":false,"given":"Christopher","family":"Christophi","sequence":"additional","affiliation":[{"name":"Surgery, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-1564","authenticated-orcid":false,"given":"Marcos Vinicius","family":"Perini","sequence":"additional","affiliation":[{"name":"Surgery, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"key":"2025100304175940000_8.1.e000487.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0189-8"},{"key":"2025100304175940000_8.1.e000487.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.0833"},{"key":"2025100304175940000_8.1.e000487.3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu260"},{"key":"2025100304175940000_8.1.e000487.4","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199909000-00004"},{"key":"2025100304175940000_8.1.e000487.5","first-page":"124","article-title":"Lack of Caudal-Type homeobox transcription factor 2 expression as a prognostic biomarker in metastatic colorectal cancer","volume":"16","author":"Zhang","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"2025100304175940000_8.1.e000487.6","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1002\/cncr.28954","article-title":"KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases","volume":"120","author":"Kemeny","year":"2014","journal-title":"Cancer"},{"key":"2025100304175940000_8.1.e000487.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.02.022"},{"key":"2025100304175940000_8.1.e000487.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.025"},{"key":"2025100304175940000_8.1.e000487.9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00010"},{"key":"2025100304175940000_8.1.e000487.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104621"},{"key":"2025100304175940000_8.1.e000487.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"2025100304175940000_8.1.e000487.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501824"},{"key":"2025100304175940000_8.1.e000487.13","doi-asserted-by":"crossref","unstructured":"Marshall HT , Djamgoz MBA . Immuno-Oncology: emerging targets and combination therapies. Front Oncol 2018;8.doi:10.3389\/fonc.2018.00315","DOI":"10.3389\/fonc.2018.00315"},{"key":"2025100304175940000_8.1.e000487.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.026"},{"key":"2025100304175940000_8.1.e000487.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-013-1021-5"},{"key":"2025100304175940000_8.1.e000487.16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00527","article-title":"Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: implications for immunotherapy","volume":"9","author":"Albini","year":"2018","journal-title":"Front Immunol"},{"key":"2025100304175940000_8.1.e000487.17","doi-asserted-by":"publisher","DOI":"10.1177\/1470320313496858"},{"key":"2025100304175940000_8.1.e000487.18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-134","article-title":"Changes in the renin angiotensin system during the development of colorectal cancer liver metastases","volume":"10","author":"Neo","year":"2010","journal-title":"BMC Cancer"},{"key":"2025100304175940000_8.1.e000487.19","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgn171"},{"key":"2025100304175940000_8.1.e000487.20","first-page":"1","article-title":"The renin-angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int J Inflam"},{"key":"2025100304175940000_8.1.e000487.21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12072-016-9705-x","article-title":"Renin\u2013angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review","volume":"10","author":"Kim","year":"2016","journal-title":"Hepatol Int"},{"key":"2025100304175940000_8.1.e000487.22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1139\/cjpp-2017-0728","article-title":"Renin\u2013angiotensin system inhibition ameliorates CCl \n                  4\n                -induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B","volume":"96","author":"Saber","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"2025100304175940000_8.1.e000487.23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/CS20120300","article-title":"Local bone marrow renin\u2013angiotensin system in primitive, definitive and neoplastic haematopoiesis","volume":"124","author":"Haznedaroglu","year":"2013","journal-title":"Clin Sci"},{"key":"2025100304175940000_8.1.e000487.24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2489"},{"key":"2025100304175940000_8.1.e000487.25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4161\/cbt.25092","article-title":"The renin angiotensin system regulates Kupffer cells in colorectal liver metastases","volume":"14","author":"Wen","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"2025100304175940000_8.1.e000487.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04797.x"},{"key":"2025100304175940000_8.1.e000487.27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cas.13423","article-title":"Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment","volume":"109","author":"Nakamura","year":"2018","journal-title":"Cancer Sci"},{"key":"2025100304175940000_8.1.e000487.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1996.tb00006.x"},{"key":"2025100304175940000_8.1.e000487.29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2443"},{"key":"2025100304175940000_8.1.e000487.30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006394","article-title":"Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: evidence from a meta-analysis including 55 studies","volume":"96","author":"Sun","year":"2017","journal-title":"Medicine"},{"key":"2025100304175940000_8.1.e000487.31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000362092","article-title":"Role of two types of angiotensin II receptors in colorectal carcinoma progression","volume":"81","author":"Zhou","year":"2014","journal-title":"Pathobiology"},{"key":"2025100304175940000_8.1.e000487.32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7150\/ijms.32599","article-title":"Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence","volume":"16","author":"Beitia","year":"2019","journal-title":"Int J Med Sci"},{"key":"2025100304175940000_8.1.e000487.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2012.02.005"},{"key":"2025100304175940000_8.1.e000487.34","doi-asserted-by":"crossref","first-page":"1009.e19","DOI":"10.1016\/j.urology.2010.11.002","article-title":"Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer","volume":"77","author":"Shirotake","year":"2011","journal-title":"Urology"},{"key":"2025100304175940000_8.1.e000487.35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018892108"},{"key":"2025100304175940000_8.1.e000487.36","doi-asserted-by":"publisher","DOI":"10.2174\/138161212799436593"},{"key":"2025100304175940000_8.1.e000487.37","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129139"},{"key":"2025100304175940000_8.1.e000487.38","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1159\/000487562","article-title":"Angiotensin II regulates Th1 T cell differentiation through angiotensin II type 1 Receptor-PKA-Mediated activation of proteasome","volume":"45","author":"Qin","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2025100304175940000_8.1.e000487.39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.930446"},{"key":"2025100304175940000_8.1.e000487.40","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0700-3"},{"key":"2025100304175940000_8.1.e000487.41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00288"},{"key":"2025100304175940000_8.1.e000487.42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00515","article-title":"Tissue-Resident memory CD8+ T cells: from phenotype to function","volume":"9","author":"Topham","year":"2018","journal-title":"Front Immunol"},{"key":"2025100304175940000_8.1.e000487.43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1877"},{"key":"2025100304175940000_8.1.e000487.44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2583"},{"key":"2025100304175940000_8.1.e000487.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.07.010"},{"key":"2025100304175940000_8.1.e000487.46","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014121214"},{"key":"2025100304175940000_8.1.e000487.47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814394116"},{"key":"2025100304175940000_8.1.e000487.48","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0692"},{"key":"2025100304175940000_8.1.e000487.49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13046-019-1126-y","article-title":"Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade","volume":"38","author":"Fang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"2025100304175940000_8.1.e000487.50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00552","article-title":"Sexual dimorphism of immune responses: a new perspective in cancer immunotherapy","volume":"9","author":"Capone","year":"2018","journal-title":"Front Immunol"},{"key":"2025100304175940000_8.1.e000487.51","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00864.2007"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2019-000487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:18:13Z","timestamp":1759490293000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2019-000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,5,24]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/jitc-2019-000487"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2019-000487","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}